Maximus vs bmiMD: Semaglutide vs Tirzepatide Pricing and Access

Looking for a telehealth weight-loss option? Maximus vs bmiMD breaks down key differences fast. Verdict: Maximus is a lower flat-rate option for compounded semaglutide prescribed by licensed doctors and filled through trusted U.S. pharmacies; bmiMD focuses on compounded tirzepatide with multiple prepaid billing options and free shipping.

Explore Maximus pricing and start telemedicine visit

Price and billing: monthly cost, plans, and commitments

Price is the clearest distinction in this Maximus vs bmiMD comparison. Maximus markets a low flat rate at $132.99 per month for compounded semaglutide, direct-pay with no membership fees and no insurance billing. bmiMD lists tirzepatide pricing by plan: $179 month-to-month, $159 for three months, $149 for six months, and $139 for a 12-month plan. bmiMD offers free shipping on every subscription order but the lowest monthly equivalent requires a longer commitment.

View bmiMD tirzepatide plans and billing options

Medication type and formulation

Maximus supplies compounded semaglutide only; their copy emphasizes once-a-week semaglutide injections and notes the medication is compounded in U.S. pharmacies. bmiMD offers compounded tirzepatide, a GLP-1/GIP option, and states the price is the same at every dose. Both vendors present compounded medication options, and both include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.

Prescribing, pharmacies, and clinician access

Both providers use licensed clinicians to review and approve prescriptions. Maximus highlights prescriptions approved by licensed doctors and filling through trusted U.S. pharmacies. bmiMD emphasizes clinician review with 24/7 clinician access and that medication is prepared in a state-licensed pharmacy with independent verification in FDA- and DEA-registered labs. bmiMD also notes treatment is available only when a licensed clinician determines it is medically appropriate.

Start Maximus telemedicine evaluation

Shipping, refunds, and availability

Both services advertise free shipping options for subscriptions: Maximus mentions free priority or expedited shipping in captured landing content; bmiMD specifically states free shipping on every subscription order. Maximus notes that if you are not approved for treatment, your medication costs will be fully refunded. bmiMD markets a 100% refundable statement if not eligible for the program and calls its offer risk free, subject to clinician determination and program eligibility.

Commitments, transparency, and suitability

Maximus positions itself as a straightforward, lower-cost, direct-pay option with no in-person visits and availability in all 50 states except Mississippi. Its cons include a smaller public track record and that it offers compounded medication only, not branded products. bmiMD positions itself for people willing to confirm eligibility and total prepaid charges before enrollment; its pros include four billing options and lower long-term monthly equivalents, while its cons note that the lowest price requires a 12-month commitment and that compounded medication is not FDA-approved.

How to choose between Maximus and bmiMD

Consider three decisive differences in this Maximus vs bmiMD matchup: medication type, pricing structure, and commitment model. Choose Maximus if you want a lower flat monthly rate for compounded semaglutide with telemedicine prescriptions filled through trusted U.S. pharmacies and availability in most states. Choose bmiMD if you prefer tirzepatide and are willing to prepay for multi-month plans to reach a lower long-term monthly equivalent and want 24/7 clinician access and verified pharmacy lab checks.

Compare bmiMD plan lengths and confirm eligibility

Review Maximus availability and start application

Final note: this comparison uses only supplied facts. Both Maximus and bmiMD provide compounded medications and clinician review. Maximus emphasizes a low flat rate for compounded semaglutide at $132.99/month and U.S. pharmacy sourcing. bmiMD emphasizes compounded tirzepatide with four billing options from $179 to $139 per month and free subscription shipping. Decide based on whether semaglutide versus tirzepatide, price structure, and commitment length matter most to you.

Choose Maximus if you want a straightforward lower monthly price for compounded semaglutide with licensed-doctor prescriptions and U.S. pharmacy fills. Choose bmiMD if you prefer compounded tirzepatide and lower long-term monthly pricing via prepaid 3 to 12 month plans with free shipping and 24/7 clinician access.